<p>Thrombin (30 nM) stimulation over 6 hours reduces the expression of (A, E) eNOS, (B, F) sGC alpha 1 and (C, G) sGC beta 1 in pulmonary artery (A–D) and pulmonary microvascular (E–H) endothelial cells, whereas (D, H) PDE5 expression is increased (White bars: control cells; grey bars: with thrombin). (I) Prolonged thrombin exposition over 14 hours leads to cGMP depletion in pulmonary endothelial cells in presence of DETA NONOate (100 µM). Data shown as mean ± SEM (A, B, C, D: n = 6/group; E, F, G, H: n = 12/group; I: n = 5–6). *<i>p</i><0.05, **<i>p</i><0.01 vs cells not exposed to thrombin.</p
<p>(A) Direct sGC-stimulator BAY 41–2272 (1 µM) und NO donor DETA NONOate (100 µM) elevate cGMP, but...
BACKGROUND: Platelet-vessel wall interaction plays an important role in acute cardiovascular disorde...
Dysfunctional endothelial cells in patients with chronic thromboembolic pulmonary hypertension. Rat...
A potential role for coagulation factors in pulmonary arterial hypertension has been recently descri...
BACKGROUND: A potential role for coagulation factors in pulmonary arterial hypertension has been rec...
<p>Left panel: Short time stimulation of HUVECs with thrombin (50 nM) increases (A) eNOS and (E) sGC...
<p>(A) Thrombin (30 nM) acutely increases cGMP content in HUVECs; the effects, however, are transien...
<p>Exposure of HUVECs to different concentration of the PAR-1 activating peptide TRAP-1 (1 to 100 µg...
The endothelium explicates its physiological functions by producing active molecules, among which ni...
Nitric oxide (NO)-cyclic GMP (cGMP) signaling is a vasoprotective pathway therapeutically targeted, ...
Pulmonary hypertension is characterized by pulmonary endothelial dysfunction. Previous work showed t...
Thrombin plays a pivotal role in the pathophysiology of acute coronary syndromes by mediating thromb...
Increased pulmonary vascular resistance in pulmonary hypertension (PH) is caused by vasoconstriction...
Pulmonary hypertension (PH) is a rare but disabling disorder, characterised by raised pulmonary arte...
Heart disease is the leading cause of death nationwide, killing one of every four Americans in all c...
<p>(A) Direct sGC-stimulator BAY 41–2272 (1 µM) und NO donor DETA NONOate (100 µM) elevate cGMP, but...
BACKGROUND: Platelet-vessel wall interaction plays an important role in acute cardiovascular disorde...
Dysfunctional endothelial cells in patients with chronic thromboembolic pulmonary hypertension. Rat...
A potential role for coagulation factors in pulmonary arterial hypertension has been recently descri...
BACKGROUND: A potential role for coagulation factors in pulmonary arterial hypertension has been rec...
<p>Left panel: Short time stimulation of HUVECs with thrombin (50 nM) increases (A) eNOS and (E) sGC...
<p>(A) Thrombin (30 nM) acutely increases cGMP content in HUVECs; the effects, however, are transien...
<p>Exposure of HUVECs to different concentration of the PAR-1 activating peptide TRAP-1 (1 to 100 µg...
The endothelium explicates its physiological functions by producing active molecules, among which ni...
Nitric oxide (NO)-cyclic GMP (cGMP) signaling is a vasoprotective pathway therapeutically targeted, ...
Pulmonary hypertension is characterized by pulmonary endothelial dysfunction. Previous work showed t...
Thrombin plays a pivotal role in the pathophysiology of acute coronary syndromes by mediating thromb...
Increased pulmonary vascular resistance in pulmonary hypertension (PH) is caused by vasoconstriction...
Pulmonary hypertension (PH) is a rare but disabling disorder, characterised by raised pulmonary arte...
Heart disease is the leading cause of death nationwide, killing one of every four Americans in all c...
<p>(A) Direct sGC-stimulator BAY 41–2272 (1 µM) und NO donor DETA NONOate (100 µM) elevate cGMP, but...
BACKGROUND: Platelet-vessel wall interaction plays an important role in acute cardiovascular disorde...
Dysfunctional endothelial cells in patients with chronic thromboembolic pulmonary hypertension. Rat...